Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.
about
Lung Basal Stem Cells Rapidly Repair DNA Damage Using the Error-Prone Nonhomologous End-Joining PathwayA consensus statement on the gender perspective in lung cancer.Drug-sensitive FGFR3 mutations in lung adenocarcinoma.DDK Promotes Tumor Chemoresistance and Survival via Multiple Pathways.Analysis of genomic variation in lung adenocarcinoma patients revealed the critical role of PI3K complexThe NF1 somatic mutational landscape in sporadic human cancers.Gene set selection via LASSO penalized regression (SLPR).IDICAP: A Novel Tool for Integrating Drug Intervention Based on Cancer Panel.Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer.The Role of Histone Protein Modifications and Mutations in Histone Modifiers in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia.Multiplatform-based molecular subtypes of non-small-cell lung cancer.Correlation between serum IL-1β and miR-144-3p as well as their prognostic values in LUAD and LUSC patients.Targeted depletion of PIK3R2 induces regression of lung squamous cell carcinomaIdentification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas.Comparative transcriptomes of adenocarcinomas and squamous cell carcinomas reveal molecular similarities that span classical anatomic boundariesGenomic approaches to accelerate cancer interception.High-depth, high-accuracy microsatellite genotyping enables precision lung cancer risk classification.Spatial distribution of EGFR and KRAS mutation frequencies correlates with histological growth patterns of lung adenocarcinomas.Epigenetic Regulation of the Epithelial to Mesenchymal Transition in Lung Cancer.The Mechanistic Role of the Calcium-Activated Chloride Channel ANO1 in Tumor Growth and Signaling.AACR Project GENIE: Powering Precision Medicine through an International Consortium.Rho GTPases: Anti- or pro-neoplastic targets?Clinicopathological significance of p14ARF expression in lung cancer: a meta-analysisGenetic variations in cancer-related significantly mutated genes and lung cancer susceptibility.The NF1 gene in tumor syndromes and melanoma.The importance of regulatory ubiquitination in cancer and metastasis.Treatment of lung adenocarcinoma by molecular-targeted therapy and immunotherapy.EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?RAS Proteins and Their Regulators in Human Disease.Molecular genetics and targeted therapy of WNT-related human diseases (Review).Integration of multiple "OMIC" biomarkers: A precision medicine strategy for lung cancer.Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities.Comparison of Prevalence and Types of Mutations in Lung Cancers Among Black and White Populations.Aligning Digital CD8(+) Scoring and Targeted Next-Generation Sequencing with PD-L1 Expression: A Pragmatic Approach in Early-Stage Squamous Cell Lung Carcinoma.Tri-methylation of H3K79 is decreased in TGF-β1-induced epithelial-to-mesenchymal transition in lung cancer.Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report.Tumor spread through air space (STAS) is an important predictor of clinical outcome in stage IA lung adenocarcinoma.Major milestones in translational oncology.Integrated analysis of dosage effect lncRNAs in lung adenocarcinoma based on comprehensive network.Questioning the role of selected somatic PIK3C2B mutations in squamous non-small cell lung cancer oncogenesis.
P2860
Q28818153-16103F7D-2AED-464E-8A68-1B4FC92519E7Q30240700-AAC0CBED-88DB-4319-8DE9-03391AF4654CQ33564782-310DEF58-89BF-47D6-963E-52E1E610FA5AQ33607399-83F80451-89B6-4ECF-8E4F-461649C88E07Q33671405-51E42B15-ADCA-493C-B604-44530B09A6EDQ33823452-FF13A441-D99B-4806-B63B-037FE684A8F8Q33878035-2FA5A00D-E2BE-4496-B74F-E40C7F281283Q37542355-603E118F-03A6-463F-B4EB-0367F820C009Q37627879-24107A5F-9172-45F4-B64E-33E2DC86AA8EQ37629537-6740994D-6D0B-46F5-BF9E-2EB687BD6746Q37691784-DF5A3E30-E171-4214-B9DE-3F6B3F54D528Q37699144-5953CA03-6EC4-4CE8-8BB2-B3DBAD1CCA55Q37709086-6F460BFC-92A1-4974-97D4-2E8187BA2112Q38599134-9E4D7DFF-3913-4A4D-871B-C0242E79BAC2Q38634656-A604D844-6323-4A13-B9B6-EEC96A04E274Q38651767-D8531DB1-E79A-4B4A-AF60-0B7A752BEFD4Q38651957-8AC69D58-5094-48C8-A674-DD95A13142CAQ38683041-BA61D7A5-6821-40F5-A2F8-1AF88366B4D7Q38696030-D27C6D96-C580-4736-8D76-5359E2CD60CEQ38745675-BB463C40-9AE0-46CE-832B-C898F1A3235DQ38749978-26A722BC-BFAA-495D-A463-609C53A7A8ACQ38780866-A9F12B37-9681-4B01-A4B9-458F61EE5296Q38784576-7360D7D9-4DA0-4D75-B39A-CA7EF26BE98EQ38850366-7A5E3BDC-151E-492B-A3EB-931E3B7E89EDQ39076849-46A68991-4AB0-4C14-8843-EA8496969883Q39122602-82FBB8D1-489A-4A3B-8F6E-064B97C0E876Q39172334-46987B71-ADA1-4F5B-9F61-233B2DC1447AQ39340502-8DE7E5D8-821B-432E-87B8-82A6FCE52690Q39407402-6B074976-8CE3-4C94-9BC4-35C120D0592BQ39450241-06584B13-FA28-4710-8214-139C85D0C7B3Q39655096-8A33734E-7A08-41EA-B708-033BDAE4D715Q40309884-E219E275-8C6D-41AC-A989-9D4CBAAD48A9Q40368173-B086303B-D21A-4E68-BFE2-65A649ADA224Q40496586-7ECF735E-A478-4752-8A12-BB4970D5582BQ41317361-A8D4EBB9-C442-41DA-BCBC-5EAFD5333DB9Q42152754-03C92DF7-F71E-40B9-B739-E692A9A2DACDQ42357315-4DA99948-6391-4C87-8300-41B59DA2F1D0Q42398020-EBB6718E-3290-423F-9A94-A4922E190D0FQ42700947-A1C3DB26-BB82-4C99-8130-5FEE19462E0CQ43636650-C4039DE3-28EC-481C-BAD2-C3A3537DAA21
P2860
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Distinct patterns of somatic g ...... and squamous cell carcinomas.
@ast
Distinct patterns of somatic g ...... and squamous cell carcinomas.
@en
type
label
Distinct patterns of somatic g ...... and squamous cell carcinomas.
@ast
Distinct patterns of somatic g ...... and squamous cell carcinomas.
@en
altLabel
Distinct patterns of somatic g ...... s and squamous cell carcinomas
@en
prefLabel
Distinct patterns of somatic g ...... and squamous cell carcinomas.
@ast
Distinct patterns of somatic g ...... and squamous cell carcinomas.
@en
P2093
P2860
P50
P356
P1433
P1476
Distinct patterns of somatic g ...... and squamous cell carcinomas.
@en
P2093
Alice H Berger
Andrew D Cherniack
Angela N Brooks
Anton Alexandrov
Aruna Ramachandran
Bradley A Murray
Carrie Cibulskis
Catherine J Wu
David J Kwiatkowski
Eric A Collisson
P2860
P2888
P304
P356
10.1038/NG.3564
P407
P50
P577
2016-05-09T00:00:00Z
P6179
1053389438